DECREASED PLASMA-PROTEIN BINDING OF VALPROATE IN PATIENTS WITH ACUTE HEAD TRAUMA

被引:30
作者
ANDERSON, GD
GIDAL, BE
HENDRYX, RJ
AWAN, AB
TEMKIN, NR
WILENSKY, AJ
WINN, HR
机构
[1] UNIV WASHINGTON,SCH PHARM,DEPT NEUROL SURG,SEATTLE,WA 98195
[2] UNIV WASHINGTON,SCH PHARM,DEPT BIOSTAT,SEATTLE,WA 98195
[3] UNIV WASHINGTON,SCH MED,SEATTLE,WA 98195
[4] UNIV WASHINGTON,SCH PUBL HLTH,SEATTLE,WA 98195
关键词
VALPROATE; PROTEIN BINDING; HYPOALBUMINEMIA; HEAD TRAUMA;
D O I
10.1111/j.1365-2125.1994.tb04304.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 One hundred and ten plasma samples were obtained from 50 patients treated with valproate for prophylaxis of post-traumatic head injuries. The samples were selected to include a wide range of albumin concentrations and were assayed for free and total valproate concentrations. Valproate binding parameters were determined from the Scatchard equation for one binding site using reweighted least squares analysis. 2 Plasma albumin concentrations were measured in 130 patients with head trauma. They started to decrease immediately after trauma, reaching a minimum at 5-7 days of approximately 24% of baseline value and did not return to normal until 1 month. 3 The free fraction of valproate varied six to seven-fold as albumin concentration ranged from 1.5 to 4.8 g 100 ml(-1) (218-696 mu mol 1(-1)). The mean association constant for binding (K-a) was 0.008 mu mol 1(-1) and the mean number of binding sites (N) was 2.0. There values were similar to those reported for valproate in otherwise healthy patients with epilepsy. 4 Because of saturable protein binding of valproate, hypoalbuminaemia may necessitate the monitoring of free valproate concentrations to avoid toxicity when valproate is used in patients with acute head injury.
引用
收藏
页码:559 / 562
页数:4
相关论文
共 28 条
[1]   CHANGES IN UNBOUND AND TOTAL VALPROIC ACID CONCENTRATIONS AFTER REPLACEMENT OF CARBAMAZEPINE WITH OXCARBAZEPINE [J].
BATTINO, D ;
CROCI, D ;
GRANATA, T ;
BERNARDI, G ;
MONZA, G .
THERAPEUTIC DRUG MONITORING, 1992, 14 (05) :376-379
[2]   IMPORTANCE OF UNBOUND PHENYTOIN SERUM LEVELS IN HEAD TRAUMA PATIENTS [J].
BAUER, LA ;
EDWARDS, WAD ;
DELLINGER, EP ;
RAISYS, VA ;
BRENNAN, C .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1983, 23 (12) :1058-1060
[3]   VALPROIC ACID CLEARANCE - UNBOUND FRACTION AND DIURNAL-VARIATION IN YOUNG AND ELDERLY ADULTS [J].
BAUER, LA ;
DAVIS, R ;
WILENSKY, A ;
RAISYS, V ;
LEVY, RH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (06) :697-700
[4]   PHENYTOIN PHARMACOKINETICS IN CRITICALLY ILL TRAUMA PATIENTS [J].
BOUCHER, BA ;
RODMAN, JH ;
JARESKO, GS ;
RASMUSSEN, SN ;
WATRIDGE, CB ;
FABIAN, TC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (06) :675-683
[5]   PROTEIN-BINDING OF VALPROIC ACID IN UREMIC PATIENTS [J].
BRUNI, J ;
WANG, LH ;
MARBURY, TC ;
LEE, CS ;
WILDER, BJ .
NEUROLOGY, 1980, 30 (05) :557-559
[6]   CONCENTRATION-EFFECT RELATIONSHIPS OF VALPROIC ACID [J].
CHADWICK, DW .
CLINICAL PHARMACOKINETICS, 1985, 10 (02) :155-163
[7]   VARIABLE FREE AND TOTAL VALPROIC ACID CONCENTRATIONS IN SOLE-DRUG AND MULTIDRUG THERAPY [J].
CRAMER, JA ;
MATTSON, RH ;
BENNETT, DM ;
SWICK, CT .
THERAPEUTIC DRUG MONITORING, 1986, 8 (04) :411-415
[8]   VALPROIC ACID - INVITRO PLASMA-PROTEIN BINDING AND INTERACTION WITH PHENYTOIN [J].
CRAMER, JA ;
MATTSON, RH .
THERAPEUTIC DRUG MONITORING, 1979, 1 (01) :105-116
[9]   APPARENT VALPROIC ACID NEUROTOXICITY IN A HYPOALBUMINEMIC PATIENT [J].
GIDAL, BE ;
COLLINS, DM ;
BEINLICH, BR .
ANNALS OF PHARMACOTHERAPY, 1993, 27 (01) :32-35
[10]   PHENYTOIN PROTEIN-BINDING IN PEDIATRIC-PATIENTS WITH ACUTE TRAUMATIC INJURY [J].
GRIEBEL, ML ;
KEARNS, GL ;
FISER, DH ;
WOODY, RC ;
TURLEY, CP .
CRITICAL CARE MEDICINE, 1990, 18 (04) :385-391